Founder of OPTM Healthcare — 35+ years in pain biochemistry

Meet Dr. Apurba Ganguly

He built OPTM around a simple idea: measure the muscle biology behind the pain, then treat that — without surgery.

35+ Years of Pain Biochemistry

Non-surgical pain care using phytotherapy and blood biomarkers, not another scan-and-refer loop.

Pain clinician, biochemist, and the person who designed this protocol

Inventor of Phytotherapy Protocols
Pioneer in AI Diagnostics for Pain
Former Head of Orthopedic Research
Awarded 'Healthcare Excellence'
"
"Most chronic pain is biology we can measure. We use blood biomarkers and muscle age, then treat with plant-based compounds and movement — not a knife, and not another painkiller prescription."
Dr. Apurba Ganguly, Founder - OPTM Healthcare
120+

Published Research

Peer-reviewed papers in international journals.

15+

Global Patents

Treatment methods filed as patents outside India.

35+

Years Experience

Pain biochemistry first, then clinic work.

100K+

Patients Treated

People treated without a joint replacement.

How the protocol was built

1988

Started pain biochemistry research

Medical College

2005

First biomarker protocol in clinic

Research Institute

2015

Brought AI diagnostics into the OPTM protocol

OPTM Healthcare

2024

100,000+ Patients Treated Across OPTM Clinics

Delhi, Kolkata, Panchkula

What clinical expertise means in a patient visit

Expertise is not a diagnosis based on an image alone. At OPTM, the clinical process begins by listening to the pattern of pain, reviewing the medical history, examining the affected area, and identifying whether the presentation is appropriate for a non-surgical pathway. Imaging and laboratory findings are interpreted as parts of that assessment rather than as a stand-alone verdict.

For knee pain, that can mean separating early-stage degenerative change from a ligament, tendon, inflammatory, or post-traumatic problem. For spine pain, it can mean checking whether symptoms point to a mechanical, neurological, referred, or systemic source. The resulting plan may combine biomarker review, guided movement, load management, manual or physical therapy, and carefully selected phytotherapeutic options.

A responsible expert also identifies when not to continue a non-surgical approach. Advanced arthritis, progressive neurological loss, infection, fracture, severe instability, or rapidly worsening symptoms may require imaging review, a surgical opinion, or another medical specialty. The aim is not surgery avoidance at any cost; it is appropriate, measurable, and safer care.

1. Establish the baseline

Record symptoms, function, relevant diagnoses, previous treatment, examination findings, and available investigation results. A clear baseline makes later change measurable and reduces the risk of attributing improvement to the wrong intervention.

2. Match the protocol to the problem

Not every pain condition responds to the same combination of tests, movement, and plant-based formulations. Treatment is staged around the diagnosis, disease grade, risk factors, and the patient's own goals for daily activity.

3. Review and escalate

Follow-up should include a documented change in pain, function, mobility, or relevant markers. If the expected response is absent, the plan should be reassessed and the patient referred when the clinical picture falls outside the scope of non-surgical care.

In the documented cohort of more than 1,000 Grade 1-3 knee patients observed from 2019 to 2024, 89% avoided a knee-replacement recommendation after the OPTM protocol. This cohort-specific figure provides useful context, but it does not predict the outcome for every patient or every stage of osteoarthritis.

Clinic visits in Delhi, Kolkata, and Panchkula

Sit with the team that built this protocol

100,000+ patients have gone through Dr. Ganguly's bloodwork-first, drug-free protocol. No surgery. No steroid series. No opioid script.

Book an Assessment

What we can actually show you

35+ years of research, published papers, and clinic outcomes — not a slogan.

100,000+

Patients Treated Across OPTM Clinics

89%

Knee-Replacement Avoidance in Documented Grade 1-3 Cohort

35+

Years of pain biochemistry research

120+

Published Medical Research Papers

Questions About OPTM's Expertise

What is OPTM's core medical expertise?
OPTM specialises in AI-powered biomarker diagnostics and phyto-molecular therapy for non-surgical musculoskeletal pain management.
How many patients has OPTM treated?
OPTM has treated over 100,000 patients since 1999. Reported outcomes vary by condition and are not a guarantee of relief for every person.